Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage

Abstract Aims Cardiac transthyretin amyloidosis (ATTR‐CM) is a progressive and fatal condition. Prognosis can be determined at diagnosis according to the National Amyloidosis Centre (NAC) transthyretin amyloidosis (ATTR) stage. We sought to examine how NAC ATTR stage changes during follow‐up and whe...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Steven Law, Aviva Petrie, Liza Chacko, Oliver C. Cohen, Sriram Ravichandran, Janet A. Gilbertson, Dorota Rowczenio, Ashutosh Wechalekar, Ana Martinez‐Naharro, Helen J. Lachmann, Carol J. Whelan, David F. Hutt, Philip N. Hawkins, Marianna Fontana, Julian D. Gillmore
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2020-12-01
Colecção:	ESC Heart Failure
Assuntos:	Amyloidosis Amyloid Transthyretin TTR Staging Cardiomyopathy
Acesso em linha:	https://doi.org/10.1002/ehf2.12989
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!